Article thumbnail

Detection of HIV-1 dual infections in highly exposed treated patients

By Guadalupe Andreani, Constanza Espada, Ana Ceballos, Juan Ambrosioni, Alejandro Petroni, Dora Pugliese, María Belén Bouzas, Silvia Fernandez Giuliano, Mercedes C Weissenbacher, Marcelo Losso, Jorge Benetucci, Jean K Carr and Liliana Martínez Peralta
Topics: Short Report
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3163559
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2008). A sudden rise in viral load is infrequently associated with HIV-1 superinfection. J Acquir Immune Defic Syndr
  2. (2007). Avila MM: Buenos Aires cohort of men who have sex with men: prevalence, incidence, risk factors, and molecular genotyping of HIV type 1. AIDS Res Hum Retroviruses
  3. (2007). Chronic HIV-1 infection frequently fails to protect against superinfection. PLoS Pathog
  4. (2009). DD: Update of the drug resistance mutations in HIV-1:
  5. (2004). Differences in frequencies of drug resistance-associated mutations in the HIV-1 pol gene of B subtype and BF intersubtype recombinant samples. J Acquir Immune Defic Syndr
  6. (2002). et al: Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users.
  7. (2004). et al: Recombination following superinfection by HIV-1. Aids
  8. (2002). et al: Two HIV-1 epidemics in Argentina: different genetic subtypes associated with different risk groups. J Acquir Immune Defic Syndr
  9. (2008). Hadany L: Drug induced superinfection in HIV and the evolution of drug resistance. Infect Genet Evol
  10. (2005). HIV type 1 fitness evolution in antiretroviral-experienced patients with sustained CD4+ T cell counts but persistent virologic failure. Clin Infect Dis
  11. (2007). Identifying HIV-1 dual infections. Retrovirology
  12. (2004). Intersubtype BF recombinants of HIV-1 in a population of injecting drug users in Argentina. J Acquir Immune Defic Syndr
  13. (2004). KH: HIV superinfection in the era of increased sexual risk-taking. Sex Transm Dis
  14. (2009). Kuritzkes DR: In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine.
  15. (2005). Little SJ: HIV drug resistance acquired through superinfection. Aids
  16. (2006). Lopez-Galindez C: A dual superinfection and recombination within HIV-1 subtype B 12 years after primoinfection. J Acquir Immune Defic Syndr
  17. (2001). Lopez-Galindez C: Different evolutionary patterns are found within human immunodeficiency virus type 1-infected patients.
  18. (2005). molecular epidemiology, and the role of recombination. Curr Infect Dis Rep
  19. (2005). Sanchez JL: Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan. J Acquir Immune Defic Syndr
  20. (2007). The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patient. J Infect Dis